Testing a new camera for detecting multiple lesions
Part of Cancer clinical trials.
This study tests whether a specialized nuclear imaging camera can better detect multiple tumors or lesions in your body. You'll receive a standard radioactive tracer scan (like a bone scan or thyroid scan) that's already part of your care, but we'll also image you with this newer camera technology to see if it works well.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have at least 2 known tumors, metastases, or lesions (spots) anywhere in your body
- Your doctor has already planned for you to have one of these scans as part of your regular care: a bone scan, a 177Lu-PSMA scan after treatment, or a radioactive iodine scan after treatment
- You are an adult (18+) and able to lie still on a table for about an hour without moving
- You are in reasonably good general health (WHO performance status 2 or better—you can do light activities)
- You have passed a medical screening and signed a consent form agreeing to participate
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests two new radioactive drugs designed to find and image advanced breast or prostate cancer. The drugs use special imaging scans (PET and SPECT) to locate tumors and may help guide future treatment decisions.
This study compares two types of scanning cameras to see how well they record images in people with thyroid cancer treated with iodine 131. It may help improve which camera gives clearer results after this treatment.
This trial tests a special camera (VERITON-CT) to help guide precise radiation for bone tumors that have spread from prostate cancer. It may improve targeting accuracy during treatment.
This study tests a new imaging agent called 64Cu-LLP2A to see if it can better detect certain blood cancers like multiple myeloma and low-grade lymphomas. It aims to find tumors more clearly than standard scans, which could help your doctor plan the best care for you.
This early-stage trial tests a new experimental drug called HT547 that combines radioactive tracers to help doctors see and treat certain solid tumors (breast, head and neck, pancreatic, or brain cancer). The study will check if the drug is safe, how it moves through your body, and how much radiation it gives you.
This trial uses a special PET scan to take pictures of certain solid tumors. The scan uses a new dye that may help doctors see the tumors more clearly. You may be eligible if you have one of the listed cancers and are between 18 and 75 years old with good daily function.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.